| 书目名称 | Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affect |
| 副标题 | Proceedings of the T |
| 编辑 | Joel Morganroth,E. Neil Moore |
| 视频video | http://file.papertrans.cn/945/944425/944425.mp4 |
| 丛书名称 | Developments in Cardiovascular Medicine |
| 图书封面 |  |
| 描述 | The Symposium on New Drugs provides for an annual forum for academic investigators, research and development personnel from the pharmaceutical and related health care industries, and members of the Food and Drug Administration to discuss important clinical research issues. The Tenth Annual Symposium on New Drugs addressed the problem of whether it was still appropriate to approve antihypertensive agents soley on the endpoint of lowering cuff blood pressure. The initial discussions at this symposium related to the approaches and methods to studying antihypertensive agents. Dr. William Frishman provided a detailed list of the new approaches to the treatment of hypertension and pointed out the many new concepts that are currently active in the development of many new antihypertensive agents. Dr. William White detailed the growing importance of ambulatory blood pressure monitoring to define hypertension and to determine the change in blood pressure due to pharmacologically active agents. Dr. Jay Cohn pointed out the flaws in using cuff blood pressure and detailed the potential virtues of using vascular compliance to identify patients requiring treatment for hypertension. Dr. Thomas Pic |
| 出版日期 | Conference proceedings 1990 |
| 关键词 | blood pressure; cardiovascular; cardiovascular disease; clinical research; clinical trial; drug; drug rese |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-1-4613-1505-6 |
| isbn_softcover | 978-1-4612-8809-1 |
| isbn_ebook | 978-1-4613-1505-6Series ISSN 0166-9842 |
| issn_series | 0166-9842 |
| copyright | Kluwer Academic Publishers 1990 |
|Archiver|手机版|小黑屋|
派博传思国际
( 京公网安备110108008328)
GMT+8, 2025-8-6 22:19
发表于 2025-3-21 19:28:17
